Fennec Pharmaceuticals (FENC) Other Working Capital Changes (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Other Working Capital Changes of $1.4 million for Q4 2025, up 296.8% year-on-year from $340727.8 in Q4 2024, and up 360.0% on a QoQ basis from -$520000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Other Working Capital Changes data on file, last reported at $1.4 million in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 296.8% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (up 259.17% YoY), and the FY2025 full-year result was $1.3 million, up 259.17% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at $1.4 million, up from -$520000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $25.1 million in Q2 2024 and bottomed at -$25.4 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is -$67000.0 (2021), against an average of $41350.0.
- The widest annual swing landed in 2022, when Other Working Capital Changes plunged 22600.0%; it then surged 13898.35% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$198000.0 in 2021, then surged by 348.48% to $492000.0 in 2022, then grew by 5.69% to $520000.0 in 2023, then plunged by 232.12% to -$687000.0 in 2024, then jumped by 296.8% to $1.4 million in 2025.
- The last three Other Working Capital Changes figures came in at $1.4 million (Q4 2025), -$520000.0 (Q3 2025), and $437000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -520,000.00 |
| Sep 30, 2025 | -520,000.00 |
| Jun 30, 2025 | 437,000.00 |
| Jun 30, 2025 | 437,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | -687,000.00 |
| Dec 31, 2024 | -687,000.00 |
| Sep 30, 2024 | -25.36 Mn |
| Sep 30, 2024 | -25.36 Mn |
| Jun 30, 2024 | 25.11 Mn |
| Jun 30, 2024 | 25.11 Mn |
| Mar 31, 2024 | 133,000.00 |
| Mar 31, 2024 | 133,000.00 |
| Dec 31, 2023 | 520,000.00 |
| Dec 31, 2023 | 520,000.00 |
| Sep 30, 2023 | -210,000.00 |
| Sep 30, 2023 | -210,000.00 |
| Jun 30, 2023 | -182,000.00 |
| Jun 30, 2023 | -182,000.00 |
| Mar 31, 2023 | -131,000.00 |
| Mar 31, 2023 | -131,000.00 |
| Dec 31, 2022 | 492,000.00 |
| Dec 31, 2022 | 492,000.00 |
| Sep 30, 2022 | -212,000.00 |
| Sep 30, 2022 | -212,000.00 |
| Jun 30, 2022 | -225,000.00 |
| Jun 30, 2022 | -225,000.00 |
| Mar 31, 2022 | -319,000.00 |
| Mar 31, 2022 | -319,000.00 |
| Dec 31, 2021 | -198,000.00 |
| Dec 31, 2021 | -198,000.00 |
| Sep 30, 2021 | 823,000.00 |
| Sep 30, 2021 | 823,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Dec 31, 2020 | -511,000.00 |
| Dec 31, 2020 | -511,000.00 |
| Sep 30, 2020 | 734,000.00 |
| Sep 30, 2020 | 734,000.00 |
| Jun 30, 2020 | -54,000.00 |
| Jun 30, 2020 | -54,000.00 |
| Mar 31, 2020 | -6,000.00 |
| Mar 31, 2020 | -6,000.00 |
| Dec 31, 2019 | -161,000.00 |
| Dec 31, 2019 | -161,000.00 |
| Sep 30, 2019 | -1,000.00 |
| Sep 30, 2019 | -1,000.00 |
| Jun 30, 2019 | -52,000.00 |
| Jun 30, 2019 | -52,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Dec 31, 2018 | 53,000.00 |
| Dec 31, 2018 | 53,000.00 |
| Sep 30, 2018 | -4,000.00 |
| Sep 30, 2018 | -4,000.00 |
| Jun 30, 2018 | -47,000.00 |
| Jun 30, 2018 | -47,000.00 |
| Mar 31, 2018 | -21,000.00 |
| Mar 31, 2018 | -21,000.00 |
| Dec 31, 2017 | -145,000.00 |
| Dec 31, 2017 | -145,000.00 |
| Sep 30, 2017 | 177,000.00 |
| Sep 30, 2017 | 177,000.00 |
| Jun 30, 2017 | -11,000.00 |
| Jun 30, 2017 | -11,000.00 |
| Mar 31, 2017 | -11,000.00 |
| Mar 31, 2017 | -11,000.00 |
| Dec 31, 2016 | 37,000.00 |
| Dec 31, 2016 | 37,000.00 |
| Sep 30, 2016 | 23,000.00 |
| Sep 30, 2016 | 23,000.00 |
| Jun 30, 2016 | -22,000.00 |
| Jun 30, 2016 | -22,000.00 |
| Mar 31, 2016 | -36,000.00 |
| Mar 31, 2016 | -36,000.00 |
| Dec 31, 2015 | -51,000.00 |
| Dec 31, 2015 | -51,000.00 |
| Sep 30, 2015 | 69,000.00 |
| Sep 30, 2015 | 69,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Mar 31, 2015 | -15,000.00 |
| Mar 31, 2015 | -15,000.00 |
| Dec 31, 2014 | 23,000.00 |
| Dec 31, 2014 | 23,000.00 |
| Sep 30, 2014 | 42,000.00 |
| Sep 30, 2014 | 42,000.00 |
| Jun 30, 2014 | -29,000.00 |
| Jun 30, 2014 | -29,000.00 |
| Mar 31, 2014 | -27,000.00 |
| Mar 31, 2014 | -27,000.00 |
| Dec 31, 2013 | 23,000.00 |
| Dec 31, 2013 | 23,000.00 |
| Sep 30, 2013 | 479,000.00 |
| Sep 30, 2013 | 479,000.00 |
| Jun 30, 2013 | -10,000.00 |
| Jun 30, 2013 | -10,000.00 |
| Mar 31, 2013 | -128,000.00 |
| Mar 31, 2013 | -128,000.00 |
| Dec 31, 2012 | -288,000.00 |
| Dec 31, 2012 | -288,000.00 |
| Sep 30, 2012 | 104,000.00 |
| Sep 30, 2012 | 104,000.00 |
| Jun 30, 2012 | -62,000.00 |
| Jun 30, 2012 | -62,000.00 |
| Mar 31, 2012 | -34,000.00 |
| Mar 31, 2012 | -34,000.00 |
| Dec 31, 2011 | -74,000.00 |
| Dec 31, 2011 | -74,000.00 |
| Sep 30, 2011 | -129,000.00 |
| Sep 30, 2011 | -129,000.00 |
| Jun 30, 2011 | -2.31 Mn |
| Jun 30, 2011 | -2.31 Mn |
| Mar 31, 2011 | 47,000.00 |
| Mar 31, 2011 | 47,000.00 |
| Dec 31, 2010 | -90,000.00 |
| Dec 31, 2010 | -90,000.00 |
| Sep 30, 2010 | 60,000.00 |
| Sep 30, 2010 | 60,000.00 |
| Jun 30, 2010 | -57,000.00 |
| Jun 30, 2010 | -57,000.00 |